KyungDong Pharm Co., Ltd. will launch “Fitroban 2mg,” a treatment for dyslipidemia, in April.

  

“Fitroban Tablet” consists of 2 mg of pitavastatin calcium and is a product that shows an LDL-C lowering effect by blocking the absorption and production of cholesterol in the liver.


“Fitroban Tablet” reduces the rate of new diabetes in patients with impaired glucose tolerance and has fewer drug interactions compared to other statin drugs.


“Fitroban Tablet” appears to be helpful in the treatment of dyslipidemia patients by significantly reducing TG and LDL-C levels and increasing HDL-C levels.

 

 

Product information

 

◈Product Name: Pitrovan Tab.

◈Ingredient content: 2mg as Pitavastatin

◈Effectiveness: Primary hypercholesterolemia

Patients before and while taking this drug must follow a standard cholesterol-lowering diet. For adults, the initial dose is usually 1 to 2 mg of pitavastatin calcium once a day. If the effect of lowering LDL-cholesterol levels is not sufficient, the dose can be increased up to 4 mg per day. Depending on the LDL-cholesterol level, treatment goals, and patient response, the dose is appropriately increased or decreased at intervals of 4 weeks or more, and the therapeutic effect of this drug is maintained with continuous administration.

(Please refer to the product manual for detailed Dosage and Administration.)

◈Packing unit: 30 tablets/bottle, 100 tablets/bottle

◈Product code: 648104380

 

※ Please refer to the product manual for other details such as precautions for use.